These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3946014)

  • 1. Altered patterns of organ distribution of autologous and grafted blood cells in mice treated with hydroxyurea.
    Lévy M
    Transplantation; 1986 Feb; 41(2):204-8. PubMed ID: 3946014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
    Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
    Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydroxyurea pretreatment of donor rats on growth of haematopoietic diffusion chamber colonies in mice.
    Ben-Ishay Z; Sharon S
    Scand J Haematol; 1977 Mar; 18(3):226-34. PubMed ID: 322255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroid stem cell regeneration in normal and plethoric mice treated with hydroxyurea.
    Seidel HJ; Opitz U
    Exp Hematol; 1979 Nov; 7(10):500-8. PubMed ID: 548283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lived lymphocytes include lipopolysaccharide-reactive B cells.
    Levy M
    Cell Immunol; 1985 Dec; 96(2):290-300. PubMed ID: 2874893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antimitotic treatment on haematopoietic tissues in mice.
    Lévy M; Raphaël M
    Ann Inst Pasteur Immunol; 1987; 138(3):347-57. PubMed ID: 3651238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of hydroxyurea to study the proliferative state of T-cell precursors (CFUT) in murine bone marrow.
    Rusthoven JJ; Phillips RA
    Exp Hematol; 1980 May; 8(5):578-83. PubMed ID: 6970140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered production and renewal of natural killer cells in B-lymphocyte-deficient CBA/N mice.
    Miller SC; Christopher FL
    Nat Immun Cell Growth Regul; 1989; 8(5):245-54. PubMed ID: 2594018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemopoietic recovery in spleen and marrow after transplantation of bone marrow from either normal or hydroxyurea treated mice.
    Hasthorpe S; Hodgson GS
    Exp Hematol; 1977 Sep; 5(5):348-56. PubMed ID: 332510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
    Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematopoiesis measured by spleen colony and diffusion chamber techniques in mice treated with one or two injections of cyclophosphamide.
    Boyum A; Carsten AL; Laerum OD
    Br J Haematol; 1974 Apr; 26(4):605-14. PubMed ID: 4845650
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy.
    Morrissey PJ; Conlon P; Charrier K; Braddy S; Alpert A; Williams D; Namen AE; Mochizuki D
    J Immunol; 1991 Jul; 147(2):561-8. PubMed ID: 1712810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population dynamics of "null" and Thy1lo lymphocytes in mouse bone marrow: genesis of cells with natural killer cell lineage characteristics.
    Rahal MD; Koo GC; Osmond DG
    Cell Immunol; 1991 Apr; 134(1):111-25. PubMed ID: 1672834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hydroxyurea on hemopoiesis in the rat after single or fractional administration].
    Haas RJ; Fache I; Bohne F; Fliedner TM
    Arzneimittelforschung; 1971 Jul; 21(7):974-8. PubMed ID: 5109512
    [No Abstract]   [Full Text] [Related]  

  • 16. Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice.
    Carlino JA; Higley HR; Creson JR; Avis PD; Ogawa Y; Ellingsworth LR
    Exp Hematol; 1992 Sep; 20(8):943-50. PubMed ID: 1505639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea kills B cell precursors and markedly reduces functional B cell activity in mouse bone marrow.
    Rusthoven JJ; Phillips RA
    J Immunol; 1980 Feb; 124(2):781-6. PubMed ID: 6965391
    [No Abstract]   [Full Text] [Related]  

  • 18. The rationale for antimitotic treatment prior to bone marrow transplantation.
    Lévy M
    Transplantation; 1986 Jun; 41(6):790-2. PubMed ID: 3520993
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth of diffusion chamber hematopoietic colonies derived from spleen cells of rats administered hydroxyurea.
    Ben-Ishay Z; Sharon S; Reichert F
    Acta Haematol; 1978; 59(2):88-98. PubMed ID: 415479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect over time of in-vivo administration of the polysaccharide arabinogalactan on immune and hemopoietic cell lineages in murine spleen and bone marrow.
    Currier NL; Lejtenyi D; Miller SC
    Phytomedicine; 2003 Mar; 10(2-3):145-53. PubMed ID: 12725568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.